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regional wall motion abnormalities, in 51/65 both observers agreed on the absense of
abnormalities on the CMR study. (sensitivity 75% and specificity 78%) The lesions were
most frequently located in the septal and anterolateral wall.
Conclusions: Functional and delayed enhanced CMR enables valuable detection and
localisation of cardiac sarcoidosis.
1169-158 Magnetic Resonance Imaging Can Reliably Identify 
Heart Iron Overload in Patients With B-Thalassemia 
Major
Sophie Mavrogeni, L. Kaklamanis, D. Tsiapras, I. Paraskevaidis, G. Karavolias, V. 
Markussis, M. Karagiorga, M. Douskou, D. V. Cokkinos, D. T. Kremastinos, Onassis 
Cardiac Surgery Center, Athens, Greece
Background: Patients with b-thalassemia major depend on continuous blood transfu-
sions for survival. As a consequence, iron overload occurs in all organs including the
heart. Heart biopsy is the only way to detect heart iron deposition, but it is invasive and
not easily repeatable. We applied magnetic resonance imaging (MRI) for the assessment
of myocardial iron deposition in patients with b-thalassemia and compared the results
with cardiac biopsy data.
Methods: Twenty-five consecutive thalassemic patients, NYHA II-III, were studied using
a 0.5 T system, ECG-gated, with TE=17-68 msec. T2 relaxation time of the interventricu-
lar septum was calculated assuming simple monoexponential decay in one square centi-
meter regions of interest. Heart biopsy was performed within a week after the MRI study. 
Results: Seven of the 25 patients had heart biopsy indicative of low iron deposition
(Group A) and the remaining 18 patients had heart biopsy indicative of high iron deposi-
tion (Group B). T2 relaxation time of the heart (T2H) was in agreement with heart biopsy
in 86% of the patients in Group A vs. 78% of the patients in Group B (overall agreement
80%). Similarly, serum ferritin levels were in agreement with heart biopsy in 28% vs.
88%, respectively (overall agreement 72%). In Group A, MRI was in better agreement
with biopsy compared to ferritin (86% vs. 28%, p<0.05).
Conclusions: Heart T2 relaxation time appears in agreement with cardiac biopsy, both in
high and low iron deposition, and is a useful non-invasive index for serial evaluation in b-
thalassemia.
1169-159 Myocardial Infarct Age Determined by Contrast-
Enhanced Cine Magnetic Resonance Imaging
Gilbert L. Raff, Ralph E. Gentry, James A. Goldstein, William Beaumont Hospital, Royal 
Oak, MI
Background
In patients with acute chest pain and resting wall motion abnormalities, differentiating
acute myocardial infarction (AMI) and chronic myocardial infarction (CMI) can have
important therapeutic implications. Contrast-enhanced cine magnetic resonance imaging
(CEC) has been shown to sensitively diagnose microvascular obtruction (MO), a signa-
ture of AMI that is rarely seen in CMI. The present study was designed to determine if
CEC can distinguish between AMI and CMI.
Methods
In 43 patients with enzyme-documented AMI treated by reperfusion, we performed CEC
within 36 hours of admission, and repeated this examination after 3 months. CEC imag-
ing was performed approximately 1 minute after 0.20mmol/kg of I.V. gadolinium-DTPA
contrast. Nine 8mm short-axis slices and two long-axis slices acquired, using an-EKG
gated, segmented k-space true-FISP pulse sequence. At 10 minutes post-injection, after
an inversion time scan for optimum myocardial nulling, an inversion-recovery turbo-
FLASH delayed hyperenhancement (IR-DE) study was done in identical slices. MO was
defined as discrete endocardially-based hypoenhancing regions that became all or par-
tially enhanced on IR-DE. All studies were read by two blinded observers.
Results
Microvascular obstruction on CEC was seen in 35/43 (81%) of patients with AMI, and in
only 4/43 (9%) after 3 months. The presence of MO on CEC 81% sensitive and 91% spe-
cific for AMI.
Conclusions
The presence of microvascular obstruction on contrast-enhanced cine MRI is a sensitive
and specific predictor of acute MI. Its absence suggests chronic MI.
1169-160 Systolic and Diastolic Strain Rates by Tagged Magnetic 
Resonance Imaging Distinguishes Regions With 
Different Degrees of Myocardial Injury After Acute 
Myocardial Infarction
Clerio F. Azevedo, Luciano C. Amado, Dara L. Kraitchman, Bernhard L. Gerber, Nael F. 
Osman, Carlos E. Rochitte, Thor Edvardsen, Joao A. Lima, Johns Hopkins Hospital, 
Baltimore, MD
Background: Myocardial injury after acute myocardial infarction (AMI) is a regional and
heterogeneous process that affects both systolic and diastolic function. Using tagged
MRI, we evaluated regional systolic and diastolic function in areas with different degrees
of myocardial injury after AMI and assessed whether both measures combined would
allow us to better characterize and distinguish these regions.
Methods: Fourteen dogs underwent 90-min coronary artery occlusion followed by reper-
fusion. Five short-axis slices were acquired for each dog within the first 24h of reperfu-
sion using 3 techniques: tagged MRI, first-pass perfusion and delayed-enhancement
(DE). Regional blood flow <50% of remote by radioactive microspheres during coronary
artery occlusion was used to define risk region. Each slice was divided in 6 segments
that were classified in 4 categories: transmural AMI (DE>50% area, n=95), subendocar-
dial AMI (DE<50% area, n=82), risk region (n=80) and remote area (n=163). For each
segment, circumferential systolic strain (Ecc), systolic strain rate (SSr) and early diastolic
strain rate (DSr) were calculated.
Results: Transmural AMI segments displayed depressed systolic contractility compared
to subendocardial AMI segments (P<0.01), and both showed reduced systolic and dias-
tolic regional function compared to remote areas (Ecc = –2.5±0.5% and –6.0±0.6% ver-
sus –13.1±0.5%, SSr = –0.11±0.10s–1 and –0.82±0.12s–1 versus –2.15±0.08s–1 and
DSr = 1.26±0.09s–1 and 1.50±0.08s–1 versus 2.99±0.10s–1, for transmural and suben-
docardial AMI segments versus remote areas, P<0.001 for all). In contrast, risk region
segments only exhibited diastolic impairment (DSr=1.62±0.09s–1, P<0.001 versus
remote), but not systolic dysfunction (NS versus remote). Importantly, after controlling for
segmental infarct extension, the presence of microvascular obstruction (“no reflow”) was
related to further impairment of systolic and diastolic regional function (P<0.05 for both).
Conclusion: Regional systolic and diastolic functional assessment using strain rate
analyses provides for superior characterization and distinction of regions with different
degrees of myocardial injury after AMI.
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1170-141 Initial Results Regarding the Safety, Tolerability, and 
Hemodynamic Effects of CVT-3146, a Selective 
Adenosine A2A Agonist, in Patients Undergoing 
Pharmacologic Stress SPECT Myocardial Perfusion 
Imaging
Robert C. Hendel, John J. Mahmarian, Timothy M. Bateman, Manuel D. Cerqueira, Ami 
E. Iskandrian, Markus Jerling, Hisham Y. Abdallah, Jeffrey A. Leppo, Rush University 
Medical Center, Chicago, IL
Background: CVT-3146 is a selective A2A adenosine receptor agonist shown to induce
coronary hyperemia and potentially procude less adverse effects due to its limited stimu-
lation of receptor subtypes not involved with coronary vasodilation. Thus, CVT-3146 may
be an effective pharmacologic stress agent.
Methods: We studied 36 subjects (27 men, 9 women; 67±10 years) with two doses of
CVT-3146 [400 mcg (n=18), 500 mcg (n=18)], administered by IV bolus, as part of a
pharmacologic stress SPECT myocardial perfusion imaging protocol.
Results: Adverse effects (AE) occurred in 26 subjects (72%), including chest discomfort
(33%), headache (25%), and abdominal pain (11%), with a similar incidence for both
doses. Flushing, dyspnea, and dizziness were more frequent in the 500-mcg group
(44%, 44%, and 28%, respectively) than in the 400-mcg group (17%, 17%, and 11%,
respectively). Most AE’s were mild to moderate (96%) and resolved within 15 minutes
without treatment (91%). One serious AE occurred, with exacerbation of a migraine
headache, requiring hospitalization. ST and T wave abnormalities developed with CVT-
3146 in 7 and 5 subjects, respectively. No 2nd or 3rd degree AV block was noted and
there were no serious arrhythmias. Peak hemodynamic effects were noted at 4 minutes
for systolic blood pressure (-5.9±10.7 mmHg) and within 2 minutes for heart rate
(+21.9±10.4 beats per minute). Systolic BP did not fall below 90 mmHg with either dose.
The mean change in HR response was higher for the 500 mcg dose than for 400 mcg.
Thirty minutes after CVT-3146, BP changes deviated <2% from baseline but HR
remained above baseline by 8.6%.
Conclusion: CVT-3146 is well-tolerated and has accceptable hemodynamic effects. Mini-
mal differences were noted in BP and HR responses between the 400 mcg and 500 mcg
doses, but AE’s were more frequent at the higher dose. CVT-3146 appears safe and well-
tolerated for bolus-mediated pharmacologic stress SPECT myocardial perfusion imaging.
1170-142 Differential Vasodilatory Effects of CVT-3146, an A2A 
Adenosine Receptor Agonist in Various Vascular Beds 
in Anesthetized Dogs
Arvinder K. Dhalla, Jiang Xu, William Kussmaul, Peter P. Kurnik, Amir Pelleg, Luiz 
Belardinelli, CV Therapeutics, Inc, Palo Alto, CA, Drexel University, College of Medicine, 
Philadelphia, PA
CVT-3146 is a novel selective A2A adenosine receptor agonist being developed as a
pharmacologic stressor for radionuclide myocardial perfusion imaging. Previously it has
been shown in awake dogs that CVT-3146 causes coronary vasodilation without signifi-
cantly affecting either total peripheral resistance or renal blood flow. The goal of this
study was to determine the differential effects of CVT-3146 on blood flow velocity in vari-
ous vascular beds. The effect of CVT-3146 on the blood flow velocity in the canine left cir-
cumflex coronary artery (LCX), brain arterial vasculature (BA), forelimb artery (FA) and
pulmonary artery (PA) of comparable diameters were quantified as the average peak
blood flow velocity (APV) using intravascular Doppler transducer-tipped catheter. CVT-
3146 (1.0 µg/kg) given as an intravenous bolus, transiently enhanced blood flow which
was site specific: APV increased 3.1+0.2, 1.4+0.1, 1.2+0.1, and 1.1+ 0.01 fold in the
LCX, BA, FA and PA, respectively manifesting a site-potency rank order of LCX
>>BA>FA>PA (figure). The effect of CVT-3146 on blood flow velocity was short lasting;
reaching a peak in less than 30 sec and dissipating in less than ten minutes. Increased
blood flow velocity was associated with a small transient increase in heart rate (16 bpm)
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and decrease in mean arterial pressure (12 mmHg). In conclusion, CVT-3146 is a potent,
short lasting vasodilator that is highly selective for the coronary vasculature.
1170-143 Diltiazem Attenuates the Coronary Vasodilatory 
Response to Adenosine and Reduces the Regional 
Myocardial Blood Flow Disparity and Sestamibi Defect 
Magnitude in Dogs With Critical Coronary Stenoses
Kengo Hatada, Mirta Ruiz, Denny D. Watson, George A. Beller, David K. Glover, 
University of Virginia Health System, Charlottesville, VA
Background: We previously showed that verapamil (Ver) markedly attenuates the
vasodilatory response to adenosine (Ado) by inhibiting KATP channels. It is unknown
whether this effect is specific to Ver or if it would also be observed with other calcium
channel blockers like diltiazem (Dtz).
Methods: In 4 anesthetized dogs, hemodynamic responses to Ado boluses (60 µg/kg)
were recorded in the absence or presence of increasing doses of Dtz (0.003-0.048 mg/
kg/min i.v.). Next, an occluder was adjusted to produce a critical LAD stenosis and an
infusion of Dtz was begun (0.048 mg/kg/min). Ten min later, Ado was infused (250 µg/kg/
min) and sestamibi (296 MBq) and microspheres were injected at peak LCx flow. Ex vivo
imaging of heart slices and gamma well counting was performed.
Results: Dtz produced dose-dependent decreases in resting HR and aortic pressure
and, as shown, increased resting flow (open bars). As with Ver, Dtz significantly attenu-
ated the LAD flow increase with Ado from 283±45% to 66±8% rest (solid bars) (p<0.05).
Likewise, Ado produced only a 2:1 myocardial flow disparity between the normal and
stenotic zones and the sestamibi defect magnitude was relatively mild (LAD/LCx count
ratio=0.74±0.02) compared with our historical data without Dtz (0.62).
Conclusion: Dtz markedly attenuated the vasodilatory response to Ado giving further
evidence that calcium channel blockers should be withheld temporarily in patients under-
going Ado stress perfusion imaging to avoid the potential for a submaximal stress test.
1170-144 Abnormal Hemodynamic Response to Adenosine and 
Poststress Left Ventricular Ejection Fraction Provide 
Incremental Prognostic Information in Patients 
Undergoing Gated Myocardial Perfusion SPECT
Aiden Abidov, Rory Hachamovitch, Alan Rozanski, Sean W. Hayes, John D. Friedman, 
Ishac Cohen, Xingping Kang, Guido Germano, Daniel S. Berman, Cedars-Sinai Medical 
Center, Los Angeles, CA, University of Southern California, Los Angeles, CA
Background: Both post-stress LVEF and abnormal heart rate (HR) response to adenos-
ine (Adeno) stress, defined as a low peak/rest HR ratio (Abnl-HRR) have been shown to
be a strong independent predictor of cardiac death (CD) in pts undergoing gated myocar-
dial perfusion SPECT (MPS). However, these variables have heretofore been assessed
in isolation so that their potential synergistic role in predicting CD is not known.
Methods: We identified 2,972 unique pts (49% women, mean age 71±11 yrs) who under-
went Adeno-MPS and were followed up for 2.7±1.3 yrs. Multivariable Cox proportional
hazards analysis was used to assess the prognostic value of clinical/MPS variables in
predicting CD. Abnl-HRR to Adeno-stress was defined as a presence of the low tercile of
peak/rest HR ratio.
Results: 201 CD (6.8%) occurred during follow-up. In a multivariable model the significant
predictors of CD were age, diabetes, shortness of breath, peak/rest HR ratio, post-stress
EF, extent and severity of stress perfusion defect, and inability to perform an adjunctive
walk, with interaction peak/rest HR*adjunctive walk. Pts with post-stress EF<35% more
often had Abnl-HRR, compared to those with higher EF (61% vs. 29%, p<0.001); how-
ever, after risk adjustment Abnl-HRR further risk-stratified pts within each EF category
(Figure).
Conclusion: An Abnl-HRR to Adeno-stress is a common finding in pts with LVEF<35%.
Abnl-HRR has an independent and incremental prognostic value among pts with either
normal or abnormal LVEF.
.
1170-145 Caffeine Acutely Decreases Coronary Flow Reserve in 
Patients With Coronary Artery Disease
Mehdi Namdar, Renate Grathwohl, Raphaël Delaloye, Pascal Koepfli, Mikel Klainguti, 
Philipp Kaufmann, University Hospital, Zurich, Switzerland
Aim: Caffeine antagonizes adenosine-induced hyperemic myocardial blood flow (MBF).
Its impact on exercise-induced coronary flow reserve (CFR) remains unknown. As exer-
cise may induce hyperemia via adenosine mediated mechanisms, our aim was to deter-
mine the acute effect of caffeine on CFR during bicycle exercise.
Methods: 15O-labelled H2O and Positron Emission Tomography (PET) was used to mea-
sure CFR in 7 patients with coronary artery disease (mean age 55y +/- 9) before and 50
minutes after oral ingestion of caffeine (200mg). Supine bicycle exercise (mean workload
98% of predicted) was used as stress.
Results: Caffeine levels were zero at baseline in all subjects and increased to 18 +/-
9mmo/l fifty minutes after caffeine intake. Rate pressure product (rest and exercise) was
not affected by caffeine. Caffeine did not affect resting MBF, whereas hyperemic MBF
decreased significantly by 20+/-20% (2.8+/-0.64 ml/min/mg vs. 2.19+/-0.58 ml/min/mg,
p=0.05), resulting in a decrease in CFR of 23% (2.16+/-0.45 vs. 1.59+/-0.33, p<0.05).
Conclusions: Intake of a caffeine dose equivalent to two cups of coffee significantly
reduces CFR in patients with CAD during physical exercise. This might raise some con-
cerns about safety of caffeine-containing food or beverages particularly when consumed
shortly before physical exercise.
1170-146 Effect of Caffeine on Fractional Flow Reserve
Gilbert J. Zoghbi, Raed Aqel, James Trimm, Shawn Baldwin, Ami Iskandrian, University 
of Alabama at Birmingham, Birmingham, AL
Background: Caffeine is believed to attenuate the coronary hyperemic response to ade-
nosine by blocking the A2a receptors. We studied the effect of caffeine on adenosine-
induced myocardial hyperemia measured by fractional flow reserve (FFR) after intracoro-
nary adenosine administration.
Methods: Patients undergoing coronary angiography and FFR determination were
enrolled (10 men, age 53±8 years, 8 whites). The FFR was measured before and 5 min-
utes after intravenous bolus caffeine administration (4mg/kg). Mean, diastolic, and sys-
tolic aortic and distal coronary pressures and heart rate were measured at 1-minute
intervals for 5 minutes after the caffeine bolus.
Results: The area stenosis by quantitative coronary angiography was 74 ± 9.0 %. The
baseline, 5 and 10-minute caffeine levels (mg/L) were 0.0±0.0, 3.7±1.8 and 3.8±1.3
respectively. Before caffeine, adenosine produced an increase in heart rate (64.7±13.8 at
rest Vs 67.6±12.9 beats/minute after adenosine, P=0.001) and a decrease in mean aortic
pressure (96.5±16.1 at rest Vs 89.4±14.1 mm Hg after adenosine, P=0.04). At 5 minutes
after caffeine administration, both mean aortic pressure (105.6±12.5 Vs 93.1±15.9 mm
Hg at baseline, P=0.005) and distal coronary pressure (94.2±14.3 Vs 82.8±15.1 mm Hg
at baseline, P=0.001) increased. The FFR before and after caffeine did not change (Fig-
ure).
